Skip to content

Application of Visual Bronchial Blockers in Pulmonary Surgery

Application of Visual Bronchial Blockers in Pulmonary Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125146
Enrollment
Unknown
Registered
2026-05-21
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary surgery

Interventions

Trial group:Bronchial blocker with visualization for lung isolation
Control group:Traditional double-lumen endobronchial tube (DLT) for lung isolation

Sponsors

The First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. No restriction on gender; aged 18–75 years old; 2. Patients scheduled for elective pulmonary surgery requiring one-lung ventilation as defined by the surgical plan; 3. American Society of Anesthesiologists (ASA) physical status class II–III; 4. The study complies with ethical requirements. Patients voluntarily participate and sign informed consent forms.

Exclusion criteria

Exclusion criteria: 1. Patients with preoperative assessment of difficult airway, or those with other high-risk factors for difficult airway who are deemed ineligible for this study by the research team; 2. Patients with a history of tracheotomy, severe airway malformation, tracheobronchial stenosis, or those requiring tracheobronchial reconstruction during surgery; 3. Patients with severe cardiopulmonary insufficiency, coagulation disorders, or allergy to related materials; 4. Patients with psychiatric disorders or cognitive dysfunction who are unable to cooperate with study procedures and follow-up; 5. Patients who have participated in another clinical drug trial within the past 30 days.

Design outcomes

Primary

MeasureTime frame
Incidence of Postoperative Pulmonary Complications (PPCs) at 7 Days Post?operation;Hoarseness;

Secondary

MeasureTime frame
Lung Collapse Score;Intraoperative respiratory parameters;Intubation time;Sore throat score;Incidence of postoperative complications at 30 days after surgery;

Countries

China

Contacts

Public ContactHe Keqiang

The First Affiliated Hospital of University of Science and Technology of China

doctorhector@ustc.edu.cn+86 189 5519 7569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026